About the Authors
- Carlos López-Gómez
-
Contributed equally to this work with: Carlos López-Gómez, Almudena Pino-Ángeles, Óscar Fernández, Laura Leyva
Affiliation Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain
- Almudena Pino-Ángeles
-
Contributed equally to this work with: Carlos López-Gómez, Almudena Pino-Ángeles, Óscar Fernández, Laura Leyva
Affiliations Department of Molecular Biology and Biochemistry, University of Málaga, Málaga, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Málaga, Spain
- Teresa Órpez-Zafra
-
Affiliations Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- María Jesús Pinto-Medel
-
Affiliations Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Begoña Oliver-Martos
-
Affiliations Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Jesús Ortega-Pinazo
-
Affiliation Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain
- Carlos Arnáiz
-
Affiliation Department of Neurology. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain
- Cristina Guijarro-Castro
-
Affiliations Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Jezabel Varadé
-
Affiliations Multiple Sclerosis Unit, Hospital Clínico San Carlos, IdISSC, Madrid, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Roberto Álvarez-Lafuente
-
Affiliations Multiple Sclerosis Unit, Hospital Clínico San Carlos, IdISSC, Madrid, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Elena Urcelay
-
Affiliations Multiple Sclerosis Unit, Hospital Clínico San Carlos, IdISSC, Madrid, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Francisca Sánchez-Jiménez
-
Affiliations Department of Molecular Biology and Biochemistry, University of Málaga, Málaga, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Málaga, Spain
- Óscar Fernández
-
Contributed equally to this work with: Carlos López-Gómez, Almudena Pino-Ángeles, Óscar Fernández, Laura Leyva
Affiliations Department of Neurology. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
- Laura Leyva
-
Contributed equally to this work with: Carlos López-Gómez, Almudena Pino-Ángeles, Óscar Fernández, Laura Leyva
* E-mail: leyvafer@gmail.com
Affiliations Research Laboratory. Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya, Málaga, Spain, Red Española de Esclerosis Múltiple (REEM RD 07/0060), Málaga, Spain
Competing Interests
Oscar Fernández, MD, PhD has received honoraria as consultant in advisory boards, and as chairmen or lecturer in meetings, and has also participated in clinical trials and other research projects promoted by Biogen-Idec, Bayer-Schering; Merck-Serono, Teva, Novartis, Almirall and Allergan. This study was partly funded by Biogen Idec Iberia S.L. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CLG LL. Performed the experiments: CLG APA TOZ MJPM BOM JOP. Analyzed the data: CLG APA TOZ MJPM BOM FSJ. Contributed reagents/materials/analysis tools: CA CGC JV RAL EU OF. Wrote the paper: CLG APA OF LL.